These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 35905888)

  • 1. The association of attained age, age at diagnosis, and duration of type 2 diabetes with the long-term risk for major diabetes-related complications.
    Morton JI; Lazzarini PA; Polkinghorne KR; Carstensen B; Magliano DJ; Shaw JE
    Diabetes Res Clin Pract; 2022 Aug; 190():110022. PubMed ID: 35905888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the Incidence of Hospitalization for Major Diabetes-Related Complications in People With Type 1 and Type 2 Diabetes in Australia, 2010-2019.
    Morton JI; Lazzarini PA; Shaw JE; Magliano DJ
    Diabetes Care; 2022 Apr; 45(4):789-797. PubMed ID: 35085387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the incidence of complications among people with diabetes according to age of onset: Findings from the UK Biobank.
    Sajjadi SF; Sacre JW; Carstensen B; Ruiz-Carmona S; Shaw JE; Magliano DJ
    Diabet Med; 2024 Sep; 41(9):e15349. PubMed ID: 38808524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019.
    Morton JI; Carstensen B; McDonald SP; Polkinghorne KR; Shaw JE; Magliano DJ
    Am J Kidney Dis; 2023 Nov; 82(5):608-616. PubMed ID: 37487818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Age of Onset of Type 2 Diabetes and the Long-term Risk of End-Stage Kidney Disease: A National Registry Study.
    Morton JI; Liew D; McDonald SP; Shaw JE; Magliano DJ
    Diabetes Care; 2020 Aug; 43(8):1788-1795. PubMed ID: 32540924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
    Koye DN; Magliano DJ; Reid CM; Pavkov ME; Chadban SJ; McDonald SP; Polkinghorne KR; White S; Paul C; Shaw JE
    Am J Kidney Dis; 2019 Mar; 73(3):300-308. PubMed ID: 30579709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients.
    Cheng LJ; Chen JH; Lin MY; Chen LC; Lao CH; Luh H; Hwang SJ
    Sci Rep; 2015 Oct; 5():15687. PubMed ID: 26507664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II.
    Drinkwater JJ; Davis TME; Hellbusch V; Turner AW; Bruce DG; Davis WA
    Cardiovasc Diabetol; 2020 Mar; 19(1):43. PubMed ID: 32234054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Trends in Cardiovascular Complications in People With or Without Type 2 Diabetes: The Fremantle Diabetes Study.
    Davis WA; Gregg EW; Davis TME
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32352534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes, myocardial infarction and stroke are distinct and duration-dependent predictors of subsequent cardiovascular events and all-cause mortality in older men.
    Yeap BB; McCaul KA; Flicker L; Hankey GJ; Almeida OP; Golledge J; Norman PE
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1038-47. PubMed ID: 25548977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
    Furtado RHM; Bonaca MP; Raz I; Zelniker TA; Mosenzon O; Cahn A; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Ruff CT; Nicolau JC; Gause-Nilsson IAM; Fredriksson M; Langkilde AM; Sabatine MS; Wiviott SD
    Circulation; 2019 May; 139(22):2516-2527. PubMed ID: 30882239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Ou SM; Chen HT; Kuo SC; Chen TJ; Shih CJ; Chen YT
    Heart; 2017 Mar; 103(6):414-420. PubMed ID: 27647170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial.
    Ferreira JP; Sharma A; Mehta C; Bakris G; Rossignol P; White WB; Zannad F
    Clin Res Cardiol; 2021 Jul; 110(7):1006-1019. PubMed ID: 32789678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess all-cause and cause-specific mortality for people with diabetes and end-stage kidney disease.
    Morton JI; Sacre JW; McDonald SP; Magliano DJ; Shaw JE
    Diabet Med; 2022 Jun; 39(6):e14775. PubMed ID: 34951712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute risk and risk factors for stroke mortality in patients with end-stage kidney disease (ESKD): population-based cohort study using data linkage.
    De La Mata NL; Alfaro-Ramirez M; Kelly PJ; Masson P; Al-Shahi Salman R; Webster AC
    BMJ Open; 2019 Feb; 9(2):e026263. PubMed ID: 30798318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database.
    Blin P; Darmon P; Henry P; Guiard E; Bernard MA; Dureau-Pournin C; Maizi H; Thomas-Delecourt F; Lassalle R; Droz-Perroteau C; Moore N
    Cardiovasc Diabetol; 2021 Nov; 20(1):229. PubMed ID: 34823531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study.
    Singh JA; Ramachandaran R; Yu S; Yang S; Xie F; Yun H; Zhang J; Curtis JR
    Arthritis Res Ther; 2017 Oct; 19(1):228. PubMed ID: 29041963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trials.
    Sacre JW; Magliano DJ; Shaw JE
    Diabetes Metab; 2021 Sep; 47(5):101249. PubMed ID: 33744399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population.
    Løgstrup BB; Ellingsen T; Pedersen AB; Darvalics B; Olesen KKW; Bøtker HE; Maeng M
    Rheumatology (Oxford); 2021 Mar; 60(3):1400-1409. PubMed ID: 32984893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials.
    Sacre JW; Magliano DJ; Shaw JE
    Diabetes Care; 2020 Oct; 43(10):2614-2623. PubMed ID: 32958618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.